Grifols

Fuatilia
Grifols executives in boardroom approving minority stake IPO for US Biopharma business, with surging stock charts on screens.
Picha iliyoundwa na AI

Grifols prepares stock listing for its US Biopharma business

Imeripotiwa na AI Picha iliyoundwa na AI

Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa